Literature DB >> 26742510

Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.

Gregory P Strauss1, Mary Vertinski2, Sally J Vogel2, Erik N Ringdahl2, Daniel N Allen3.   

Abstract

Past studies have demonstrated that the Brief Negative Symptom Scale (BNSS) has excellent psychometric properties in patients with schizophrenia. In the current study, we extended this literature by examining psychometric properties of the BNSS in outpatients diagnosed with bipolar disorder (n=46), outpatients with schizophrenia (n=50), and healthy controls (n=27). Participants completed neuropsychological testing and a clinical interview designed to assess negative, positive, disorganized, mood, and general psychiatric symptoms. Results indicated differences among the 3 groups in the severity of all BNSS items, with SZ and BD scoring higher than CN; however, SZ and BD only differed on blunted affect and alogia items, not anhedonia, avolition, or asociality. BD patients with a history of psychosis did not differ from those without a history of psychosis on negative symptom severity. The BNSS had excellent internal consistency in SZ, BD, and CN groups. Good convergent and discriminant validity was apparent in SZ and BD groups, as indicated by relationships between the BNSS and other clinical rating scales. These findings support the validity of the BNSS in broadly defined serious mental illness populations.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alogia; Anhedonia; Asociality; Avolition; Bipolar disorder; Restricted affect

Mesh:

Substances:

Year:  2015        PMID: 26742510     DOI: 10.1016/j.schres.2015.12.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Revisiting how People with Schizophrenia Spend Their Days: Associations of lifetime milestone Achievements with Daily Activities examined with Ecological Momentary Assessment.

Authors:  Michelle M Perez; Bianca A Tercero; Fiorella Durand; Felicia Gould; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Psychiatry Res Commun       Date:  2022-06-26

2.  Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Ian M Raugh; Luyu Zhang; Lauren Luther; Hannah C Chapman; Daniel N Allen; Brian Kirkpatrick; Alex S Cohen
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-15

3.  Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.

Authors:  Gregory Paul Strauss; Farnaz Zamani Esfahlani; Brian Kirkpatrick; Daniel N Allen; James M Gold; Katherine Frost Visser; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

4.  Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome.

Authors:  Ian M Raugh; Sydney H James; Cristina M Gonzalez; Hannah C Chapman; Alex S Cohen; Brian Kirkpatrick; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

5.  A Meta-Analysis of Neuropsychological Effort Test Performance in Psychotic Disorders.

Authors:  Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Gregory P Strauss
Journal:  Neuropsychol Rev       Date:  2020-08-07       Impact factor: 7.444

Review 6.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

7.  Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.

Authors:  Martin T Strassnig; Michelle L Miller; Raeanne Moore; Colin A Depp; Amy E Pinkham; Philip D Harvey
Journal:  Psychiatry Res       Date:  2021-04-04       Impact factor: 11.225

8.  Magnetic resonance imaging DTI-FT study on schizophrenic patients with typical negative first symptoms.

Authors:  Chengyu Gu; Ying Zhang; Fuquan Wei; Yougen Cheng; Yulin Cao; Hongtao Hou
Journal:  Exp Ther Med       Date:  2016-06-17       Impact factor: 2.447

9.  Imaging Habenula Volume in Schizophrenia and Bipolar Disorder.

Authors:  Matthew Schafer; Joo-Won Kim; Joshmi Joseph; Junqian Xu; Sophia Frangou; Gaelle E Doucet
Journal:  Front Psychiatry       Date:  2018-09-24       Impact factor: 4.157

10.  The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Authors:  Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-21       Impact factor: 5.270

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.